Homer K L, Wanstall J C
Pulmonary Pharmacology Group, Department of Physiology and Pharmacology, The University of Queensland, St Lucia, Brisbane, Qld. 4072, Australia.
Br J Pharmacol. 2000 Oct;131(4):673-82. doi: 10.1038/sj.bjp.0703613.
In rat pulmonary artery pre-contracted with phenylephrine, the mechanisms of relaxation to the nitric oxide (NO) donor, spermine NONOate, were investigated. Responses to spermine NONOate were only partially blocked by the soluble guanylate cyclase inhibitor, ODQ (1H:-[1,2,4]Oxadiazolo-[4,3,-a]quinoxalin-1-one) at concentrations up to 30 microM. Ten microM ODQ gave maximal inhibition. Endothelium removal had no effect on the potency of spermine NONOate or its inhibition by ODQ. The protein kinase G inhibitor, Rp-8-Br-cGMPS (100 microM), caused minimal inhibition of spermine NONOate despite causing marked inhibition of glyceryl trinitrate and isosorbide dinitrate. Spermine NONOate (100 microM) caused a 35 fold increase in guanosine 3'5' cyclic monophosphate (cyclic GMP) above basal levels in pulmonary artery rings. ODQ (3 microM) abolished this cyclic GMP production but did not inhibit corresponding relaxant responses. Similar results were seen with another NONOate (MAHMA NONOate; 10 microM). ODQ-resistant relaxation to spermine NONOate (i. e. relaxation seen in the presence of 10 microM ODQ) was inhibited by potassium (80 mM), charybdotoxin (300 nM), iberiotoxin (300 nM), apamin (100 nM), ouabain (1 mM) or thapsigargin (100 nM) but not by 4-aminopyridine (3 mM), glybenclamide (10 microM) or diltiazem (10 microM). Potassium, charybdotoxin, ouabain and thapsigargin also inhibited ODQ-resistant relaxation to FK409 ((+/-)-E:-4-ethyl-2-[E:-hydroxyimino]-5-nitro-3-hexenamide). We conclude that, on rat pulmonary artery, spermine NONOate can produce cyclic GMP-independent relaxation that involves, at least in part, activation of Na(+)/K(+)-ATPase, sarco-endoplasmic reticulum Ca(2+)-ATPase and calcium-activated potassium channels.
在苯肾上腺素预收缩的大鼠肺动脉中,研究了对一氧化氮(NO)供体精胺NONOate的舒张机制。在浓度高达30μM时,可溶性鸟苷酸环化酶抑制剂ODQ(1H:-[1,2,4]恶二唑并-[4,3,-a]喹喔啉-1-酮)仅部分阻断了对精胺NONOate的反应。10μM的ODQ产生最大抑制作用。去除内皮对精胺NONOate的效力或其被ODQ的抑制作用没有影响。蛋白激酶G抑制剂Rp-8-Br-cGMPS(100μM)对精胺NONOate的抑制作用最小,尽管它对硝酸甘油和异山梨醇二硝酸酯有明显抑制作用。精胺NONOate(100μM)使肺动脉环中的鸟苷3',5'-环磷酸(环鸟苷酸)水平比基础水平增加了35倍。ODQ(3μM)消除了这种环鸟苷酸的产生,但没有抑制相应的舒张反应。另一种NONOate(MAHMA NONOate;10μM)也得到了类似结果。对精胺NONOate的ODQ抗性舒张(即在10μM ODQ存在下观察到的舒张)被钾(80mM)、蝎毒素(300nM)、iberiotoxin(300nM)、蜂毒明肽(100nM)、哇巴因(1mM)或毒胡萝卜素(100nM)抑制,但不被4-氨基吡啶(3mM)、格列本脲(10μM)或地尔硫䓬(10μM)抑制。钾、蝎毒素、哇巴因和毒胡萝卜素也抑制了对FK409((+/-)-E:-4-乙基-2-[E:-羟基亚氨基]-5-硝基-3-己烯酰胺)的ODQ抗性舒张。我们得出结论,在大鼠肺动脉上,精胺NONOate可产生不依赖环鸟苷酸的舒张,这至少部分涉及钠/钾-ATP酶、肌浆网钙-ATP酶和钙激活钾通道的激活。